CBD Pet Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global CBD Pet Market is projected to expand significantly, growing from USD 256.48 Million in 2025 to USD 506.52 Million by 2031, reflecting a compound annual growth rate of 12.01%. This market sector includes hemp-derived cannabidiol products, such as topicals, chews, and oils, developed to relieve inflammation, pain, and anxiety in companion animals. Key drivers propelling this industry include the increasing humanization of pets and a consumer shift toward natural, holistic health alternatives rather than traditional pharmaceuticals. This transition is supported by strong safety records; according to 2024 data from the National Animal Supplement Council, adverse events for CBD products occurred at a rate of only 2.1 per one million administrations, reinforcing consumer trust in these therapies.

Despite this growth, regulatory uncertainty remains a significant barrier to wider market development. The lack of federal approval for CBD as a veterinary feed additive and inconsistent legal frameworks create compliance burdens that prevent veterinary professionals from officially prescribing these products. This absence of standardization complicates interstate trade and limits the ability of major retailers to fully adopt the category. Consequently, the industry faces challenges in achieving broader commercial acceptance due to these ongoing regulatory complexities.

Market Drivers

The escalating trend of pet humanization and premiumization acts as a primary driver for the Global CBD Pet Market, fundamentally reshaping consumer purchasing habits. As owners increasingly regard their pets as essential family members, there is a greater willingness to invest in high-quality, wellness-oriented products that align with human health trends.

According to Forbes Advisor in October 2025, 51% of pet owners consider their animals to be as integral to the family as human members. This strong emotional connection fuels the demand for premium care options, contributing substantially to the industry's financial strength. Data from the American Pet Products Association's '2025 State of the Industry Report', released in March 2025, indicates that total U.S. pet industry spending reached $152 billion in 2024, highlighting the vast economic scale of the owner-pet bond that CBD brands are leveraging to position their products as wellness necessities.

Concurrently, the rising prevalence of chronic and age-related ailments in pets provides a direct pathway for the adoption of natural remedies. Owners are actively seeking holistic substitutes for conventional pharmaceuticals to manage issues like behavioral stress and mobility problems, which are primary use cases for cannabidiol. The American Pet Products Association reported in its '2024 Dog and Cat Report' from August 2024 that the usage of calming products for dogs has surged by 168% since 2018. This increase underscores a distinct consumer pivot toward anxiety-relief solutions, directly benefiting CBD formulations designed to mitigate stress. As the demand for functional pain and anxiety management grows, the market for CBD-infused treats and oils continues to expand to meet these therapeutic needs.

Market Challenges

Regulatory ambiguity acts as a major hurdle restricting the commercial scalability of the global CBD pet market. The lack of federal designation for CBD as an approved feed additive creates significant liability risks, discouraging major national retailers from stocking these products. This exclusion from high-traffic sales channels forces distribution into fragmented online and specialty markets, thereby limiting consumer visibility and accessibility. Furthermore, the absence of federal oversight prevents veterinary professionals from endorsing these therapies, effectively severing the critical connection between medical advice and product adoption.

This restriction on market maturation persists despite clear evidence of consumer demand. In 2024, the American Pet Products Association reported that 12% of dog owners utilized CBD products for their pets, demonstrating a viable customer base. However, continued legal uncertainty functions as a bottleneck, preventing the sector from capitalizing on this interest to achieve mass adoption. Without a standardized regulatory framework to assure safety and legality, the industry remains unable to unlock its full growth potential through integration into mainstream retail markets.

Market Trends

The adoption of nano-emulsion technology is transforming product efficacy by addressing the naturally low bioavailability associated with traditional lipid-based cannabinoids. Manufacturers are increasingly using this advanced processing method to break down CBD oil into microscopic particles, significantly increasing the surface area for absorption within a pet's digestive tract. This innovation enables water-soluble formulations that ensure more consistent therapeutic outcomes and faster onset times compared to conventional tinctures. A study published in Frontiers in Veterinary Science in April 2024, titled 'Pharmacokinetics behavior of four cannabidiol preparations following single oral administration in dogs', revealed that nano-emulsion based formulations achieved maximum plasma concentrations in the range of 92-314 μg/L within three hours, outperforming other delivery methods in rapid absorption.

Simultaneously, the market is undergoing a phase of consolidation through strategic acquisitions, signaling the entry of established animal health and equity firms into the space. This trend highlights a shift from fragmented, small-scale operations toward a matured landscape where capital investment drives scalability and distribution reach. Large entities are acquiring successful supplement brands to diversify portfolios and capitalize on the established trust these niche players have built. As noted by Petfood Industry in December 2024 regarding 'Pet industry M&As set to surge in 2025', the sector's financial evolution was exemplified by the acquisition of FoodScience pet supplements by private equity investors in late November, illustrating the heightened institutional interest in high-quality nutritional assets.

Key Players Profiled in the CBD Pet Market

• Honest Paws
• Canna-Pet
• FOMO Bones
• Pet Releaf
• HolistaPet
• Joy Organics
• Wet Noses Inc.
• CBD Living
• Petstock Pty Ltd.
• Petco Animal Supplies, Inc.

Report Scope

In this report, the Global CBD Pet Market has been segmented into the following categories:

CBD Pet Market, by Animal Type:

• Dogs
• Cats
• Others

CBD Pet Market, by Indication:

• Joint Pain
• Anxiety/Stress
• Epilepsy
• General Health/Wellness
• Other Indications

CBD Pet Market, by Distribution Channel:

• Pet Specialty Stores
• E-Commerce
• CBD Stores
• Others

CBD Pet Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global CBD Pet Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.